Stoke Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Stoke Therapeutics, Inc. (STOK) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -1.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-03-16
- Stoke Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was -1.00%.
- Stoke Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was -1.10%.
- Stoke Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was -0.90%, a 325.00% decline from fiscal 2021.
- Stoke Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2021 was 0.40%, a 93.55% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|
| 2024-12-31 | -1.00% 10-K · filed 2026-03-16 |
| 2023-12-31 | -1.10% 10-K · filed 2025-03-18 |
| 2022-12-31 | -0.90% 10-K · filed 2024-03-25 |
| 2021-12-31 | 0.40% 10-K · filed 2023-03-06 |
| 2020-12-31 | 6.20% 10-K · filed 2022-03-10 |
| 2019-12-31 | -0.40% 10-K · filed 2021-03-09 |
| 2018-12-31 | -0.30% 10-K · filed 2020-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |